Molecular Diagnosis of Tuberculosis and Drug Resistance-Reference-Cited by-同舟云学术

Molecular Diagnosis of Tuberculosis and Drug Resistance

Published:2014-06 Issue:2 Volume:34 Page:297-314
ISSN:0272-2712
Container-title:Clinics in Laboratory Medicine
language:en
Short-container-title:Clinics in Laboratory Medicine

Author:

Lin Shou-Yean Grace,Desmond Edward P.

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry

Reference74 articles.

1. Reported tuberculosis in the United States, 2012;CDC,2013

2. Unexpected high levels of multidrug-resistant tuberculosis present new challenges for tuberculosis control;Hoffner;Lancet,2012

3. WHO. Global tuberculosis report. 2013. Geneva (Switzerland): World Health Organization. Available at: http://wh1libdoc.who.int/publications/2013/9789241564656_eng.pdf. WHO/HTM/TB/2013.11.

4. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report in surveillance and response;WHO,2011

5. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Policy statement;WHO,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lineage classification and antitubercular drug resistance surveillance of Mycobacterium tuberculosis by whole-genome sequencing in Southern India;Microbiology Spectrum;2023-10-17

2. Rifampicin-resistant TB: discordance between Xpert® MTB/RIF and MTBDRplus results;The International Journal of Tuberculosis and Lung Disease;2021-10-01

3. Development and Validation of Signature Sequence–Based PCR for Improved Molecular Diagnosis of Tuberculosis;The Journal of Molecular Diagnostics;2021-09

4. Detection of mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains inhibiting wild type probe hybridization in the MTBDR plus assay by DNA sequencing directly from clinical specimens;BMC Microbiology;2020-09-16

5. Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services;The Lancet Infectious Diseases;2020-02